Pharvaris N.V. share price logo

Pharvaris N.V.

NASDAQ: PHVS

Mid Cap

$34.71

+1.29

(+3.86%)

Live

as on

Pharvaris N.V. Stock Performance

as on August 7, 2026 at 6:11 am IST

  • Day's Low

    Day's High

    $33.60
    $36.02
    downward going graph

    3.20%

    Downside

    3.77%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $19.56
    $36.60
    downward going graph

    43.65%

    Downside

    5.45%

    Upside

    downward going graph

Pharvaris N.V. share price movements today

Previous Close
$33.42
Open
$33.60
Volume
252.8K
Day's Low - High
$33.60 - $36.02
52 Week Low - High
$19.56 - $36.60

Pharvaris N.V. Historical Returns

1 Month Return
-3.38 %
3 Month Return
+ 12.6 %
1 Year Return
+ 64.47 %
3 Year Return
+ 90.75 %
5 Year Return
+ 107.97 %

Pharvaris N.V. Stock Fundamentals & Key Indicators

Check Pharvaris N.V. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

-2.6466

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-171.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-73.02%

Pharvaris N.V. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pharvaris N.V. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Pharvaris N.V. image
Pharvaris N.V.
BUY$2.4B107.97%NA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$41.1B605.15%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$121.3B141.61%27.9335.00%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$78.3B25.82%18.827.87%0.48%

Stock Returns calculator for Pharvaris N.V. Stock including INR - Dollar returns

The Pharvaris N.V. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pharvaris N.V. investment value today

Current value as on today

₹1,85,152

Returns

₹85,152

(+85.15%)

Returns from Pharvaris N.V. Stock

₹70,817 (+70.82%)

Dollar Impact

₹14,335 (+14.33%)

Analyst Recommendation on Pharvaris N.V. Stock

Based on 13 analysts

BUY

84.62%

Buy

7.69%

Hold

7.69%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Pharvaris N.V.. Average target price of $48.35

Pharvaris N.V. Share Price Target

Get share price movements and forecasts by analysts on Pharvaris N.V..

What analysts predicted

28.21%UPSIDE

Target Price

$48.35

Current Price

$34.71

Analyzed by

13 Analysts

Target

$48.35

Pharvaris N.V. target price $48.35, a slight upside of 28.21% compared to current price of $34.71. According to 13 analysts rating.

Indian Investors' Interest in Pharvaris N.V. Stock

Search interest for Pharvaris N.V. Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:7% versus previous 30 day period

Pharvaris N.V. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
-
-
0
-
-
-
0
Operating Income
-27
-28
-34
-37
-45
42
-40
-39
-47
-45
EBITDA
-
-27
-29
-41
-
-42
-45
-37
-
-39
Interest Expense
-
0
2
0
-
-
-
-
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-31
-27
-29
-41
-33
-46
-45
-37
-45
-39
Income Tax Expense
-
0
0
0
-
0
0
0
-
0
Net Income
-35
-30
-31
-46
-36
-50
-45
-37
-46
-39
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pharvaris N.V. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
-
-
Operating Income
-4
-8
-28
-54
-86
-96
-145
-169
EBITDA
-4
-8
-29
-42
-86
-99
-145
-173
Interest Expense
-
0
0
0
0
0
-
-
Depreciation
-
0
0
0
0
0
0
0
Income Before Tax
-4
-8
-29
-42
-75
-99
-132
-173
Income Tax Expense
0
0
0
0
0
1
1
1
Net Income
-4
-9
-36
-48
-80
-110
-140
-175
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pharvaris N.V. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-27
-29
-41
-34
-46
-45
-37
-46
-39
Operating Cash Flow
-24
-27
-33
-34
-38
-29
-30
-37
-49
Investing Cash Flow
0
0
0
-
0
0
0
-
0
Financing Cash Flow
0
0
0
0
0
0
160
0
0
Change in Cash
-22
-24
-38
-34
-44
-36
129
-37
-50

Pharvaris N.V. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-8
-26
-42
-75
-99
-132
-173
Operating Cash Flow
-6
-21
-44
-67
-93
-120
-137
Investing Cash Flow
0
0
0
0
0
0
0
Financing Cash Flow
21
101
143
8
325
2
160
Change in Cash
14
78
110
-47
229
-110
10

Global Institutional Holdings in Pharvaris N.V.

Funds
Holdings
AllianceBernstein L.P.
0.01%
Deerfield Management Co
4.47%
The Goldman Sachs Group Inc
0.25%
Bain Capital Life Sciences Investors, LLC
3.83%
EQT Fund Management S.à r.l.
4.9%
See all

Pharvaris N.V. News & Key Events

  • img

    Today's Timeline - 15 July

    Wed, 06:06 PM

    -

    Wells Fargo initiates coverage on Pharvaris with an overweight rating and a $55 price target.

    Wed, 09:30 PM

    -

    Pharvaris shows strong momentum with a Zacks Rank of #2 and significant share price increases over various timeframes.

Insights on Pharvaris N.V.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, PHVS stock has moved up by 26.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 438.0% return, outperforming this stock by 380.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 532.2% return, outperforming this stock by 454.6%

About Pharvaris N.V.

Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
OrganisationPharvaris N.V.
HeadquartersGrafenauweg 8, Zug, Switzerland, 6300
IndustryBiotechnology
CEOMr. Berndt Axel Edvard Modig CPA, M.B.A.
E-voting on sharesClick here to vote

Key Management of Pharvaris N.V.

Name

Title

Mr. Wim Souverijns Ph.D.

Chief Commercial Officer

Dr. Peng Lu M.D., Ph.D.

President

Ms. Annick Deschoolmeester

Chief Human Resources Officer

Dr. Anne A. Lesage Ph.D.

Chief Early Development Officer

Dr. Stefan Abele Ph.D.

Chief Technology Operations Officer

Maryann Cimino

Director of Corporate Relations

Mr. Berndt Axel Edvard Modig CPA, M.B.A.

Co-Founder, CEO & Executive Director

Mr. David W. Nassif J.D.

CFO, Chief Legal Officer & Corporate Secretary

Ms. Anna Nijdam M.Sc., R.A.

Head of Strategic Finance & Principal Accounting Officer

FAQs

What is Pharvaris N.V. share price today?

Pharvaris N.V. share price today is $34.71 as on . Pharvaris N.V. share today touched a day high of $36.02 and a low of $33.60.

What is the 52 week high and 52 week low for Pharvaris N.V. share?

Pharvaris N.V. share touched a 52 week high of $36.60 on and a 52 week low of $19.56 on . Pharvaris N.V. stock price today i.e. is trending at $34.71,which is 5.16% down from its 52 week high and 77.45% up from its 52 week low.

What is Pharvaris N.V.'s market capitalisation today?

Pharvaris N.V. market capitalisation is $0.00T as on .

How to invest in Pharvaris N.V. Stock (PHVS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pharvaris N.V. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pharvaris N.V. Shares that will get you 0.0432 shares as per Pharvaris N.V. share price of $34.71 per share as on August 7, 2026 at 12:41 am IST.

What is the minimum amount required to buy Pharvaris N.V. Stock (PHVS) from India?

Indian investors can start investing in Pharvaris N.V. (PHVS) shares with as little as ₹95.2 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Pharvaris N.V. stock (as per the Rupee-Dollar exchange rate as on ). Based on Pharvaris N.V. share’s latest price of $34.71 as on August 7, 2026 at 12:41 am IST, you will get 0.2881 shares of Pharvaris N.V.. Learn more about fractional shares .

What are the returns that Pharvaris N.V. has given to Indian investors in the last 5 years?

Pharvaris N.V. stock has given 107.97% share price returns and 28.66% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?